We've found
184,457
clinical trials
CONGESTIVE HEART FAILURE Clinical Trial
His Bundle Pacing Versus Coronary Sinus Pacing for Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
CONGESTIVE HEART FAILURE Clinical Trial
His Bundle Pacing Versus Coronary Sinus Pacing for Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
The Cxbladder Monitoring Study
Status: Enrolling
Updated: 3/4/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
The Cxbladder Monitoring Study
Status: Enrolling
Updated: 3/4/2016
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Vaginal Electrical Stimulation for Postpartum Neuromuscular Recovery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MPS I Clinical Trial
Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Brain Aging Clinical Trial
Committed Actions for Successful Aging
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Polymyalgia Rheumatica Clinical Trial
Delayed Release Prednisone in PMR
Status: Enrolling,
Phase
IV
Updated: 3/3/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Employing eSBI in HIV Testing for At-risk Youth
Status: Enrolling
Updated: 1/30/2018
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Employing eSBI in HIV Testing for At-risk Youth
Status: Enrolling
Updated: 1/30/2018
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Dynamic Allocation Modular Sequential Trial of Approved and Promising Therapies in Men With Metastatic Castrate Resistant Prostate Cancer (DynaMO)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)
Status: Enrolling,
Phase
II
Updated: 4/30/2018
Click here to add this to my saved trials
Immunology / Infectious Diseases, Musculoskeletal Clinical Trial
Acupuncture for Vulvodynia: A Pre-pilot Study
Status: Enrolling
Updated: 3/8/2016
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Suvorexant and Trauma Related Insomnia
Status: Enrolling,
Phase
IV
Updated: 3/28/2018
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
Safety and Efficacy Study in Recurrent Grade IV Glioma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Oncology Clinical Trial
A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Biobanking of Rett Syndrome and Related Disorders
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Biobanking of Rett Syndrome and Related Disorders
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Biobanking of Rett Syndrome and Related Disorders
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Endocrinology Clinical Trial
Complex Effects of Dietary Manipulation on Metabolic Function, Inflammation and Health
Status: Enrolling
Updated: 4/6/2018
Click here to add this to my saved trials
Oncology Clinical Trial
JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Williams Syndrome (WS) and Supravalvular Aortic Stenosis (SVAS) DNA and Tissue Bank
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Clinical Trial
The Effect of Dopamine on Diabetic Retinopathy
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Limb Ischemia Clinical Trial
Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Sapanisertib and Osimertinib in Treating Patients With Stage IV EGFR Mutation Positive Non-small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 10/27/2017
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
TG02 Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of TG02 Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
CONGESTIVE HEART FAILURE Clinical Trial
Updated: 12/31/1969
His Bundle Pacing Versus Coronary Sinus Pacing for Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
CONGESTIVE HEART FAILURE Clinical Trial
Updated: 12/31/1969
His Bundle Pacing Versus Coronary Sinus Pacing for Cardiac Resynchronization Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 3/4/2016
The Cxbladder Monitoring Study
Status: Enrolling
Updated: 3/4/2016
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 3/4/2016
The Cxbladder Monitoring Study
Status: Enrolling
Updated: 3/4/2016
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Updated: 12/31/1969
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Updated: 12/31/1969
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Updated: 12/31/1969
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Updated: 12/31/1969
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Updated: 12/31/1969
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Updated: 12/31/1969
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Updated: 12/31/1969
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Updated: 12/31/1969
Vaginal Electrical Stimulation for Postpartum Neuromuscular Recovery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MPS I Clinical Trial
Updated: 12/31/1969
Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Brain Aging Clinical Trial
Updated: 12/31/1969
Committed Actions for Successful Aging
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Polymyalgia Rheumatica Clinical Trial
Updated: 3/3/2016
Delayed Release Prednisone in PMR
Status: Enrolling,
Phase
IV
Updated: 3/3/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Updated: 1/30/2018
Employing eSBI in HIV Testing for At-risk Youth
Status: Enrolling
Updated: 1/30/2018
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Updated: 1/30/2018
Employing eSBI in HIV Testing for At-risk Youth
Status: Enrolling
Updated: 1/30/2018
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
A Dynamic Allocation Modular Sequential Trial of Approved and Promising Therapies in Men With Metastatic Castrate Resistant Prostate Cancer (DynaMO)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 4/30/2018
Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)
Status: Enrolling,
Phase
II
Updated: 4/30/2018
Click here to add this to my saved trials
Immunology / Infectious Diseases, Musculoskeletal Clinical Trial
Updated: 3/8/2016
Acupuncture for Vulvodynia: A Pre-pilot Study
Status: Enrolling
Updated: 3/8/2016
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Updated: 3/28/2018
Suvorexant and Trauma Related Insomnia
Status: Enrolling,
Phase
IV
Updated: 3/28/2018
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study in Recurrent Grade IV Glioma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Updated: 12/31/1969
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Updated: 4/5/2018
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling,
Phase
Updated: 4/5/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 4/18/2018
Biobanking of Rett Syndrome and Related Disorders
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 4/18/2018
Biobanking of Rett Syndrome and Related Disorders
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 4/18/2018
Biobanking of Rett Syndrome and Related Disorders
Status: Enrolling,
Phase
Updated: 4/18/2018
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 4/6/2018
Complex Effects of Dietary Manipulation on Metabolic Function, Inflammation and Health
Status: Enrolling
Updated: 4/6/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Updated: 12/31/1969
Williams Syndrome (WS) and Supravalvular Aortic Stenosis (SVAS) DNA and Tissue Bank
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Clinical Trial
Updated: 12/31/1969
The Effect of Dopamine on Diabetic Retinopathy
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Limb Ischemia Clinical Trial
Updated: 12/31/1969
Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Sapanisertib and Osimertinib in Treating Patients With Stage IV EGFR Mutation Positive Non-small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Updated: 10/27/2017
Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 10/27/2017
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
TG02 Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of TG02 Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Updated: 12/31/1969
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Updated: 12/31/1969
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Updated: 12/31/1969
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Updated: 12/31/1969
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Updated: 12/31/1969
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials